The Translational Genomics Research Institute (TGen) is pleased to announce the 2013 application opening for the Helios Scholars paid summer internship program in biomedical research!Continue reading
Category Archives: Blogs
AZBio Blogs
A bit of certainty for biotech investors and innovators added to “The Fiscal Cliff Bill” this week
This week’s “Fiscal Cliff Bill” included some key provisions that help support biotech innovations here in Arizona. Continue reading
Stimwave joins BioInspire Incubator
BioAccel Adds Stimwave Technologies To BioInspire Medical Device Incubator. Stimwave Becomes Sixth Company in 3 months to join the BioInspire Incubator Model Moving Innovations to Commercialization for ArizonaContinue reading
Moving Up The Ranks
Over the last decade, Arizona’s bioscience sector has made amazing progress in building foundational infrastructure for research and discovery in the life science sector. This next decade of focused collaboration is our opportunity to move up the ranks and along the path from Discovery to Development to Delivery. Continue reading
BioCentury This Week – Heathcare Reset: What’s on the Table
BioCentury This Week looks at What’s on the Table for Innovation and HealthcareContinue reading
State Net Capitol Journal 12 17 2012
AZBio partners with LexisNexis and State Net to bring you all the latest updates from Washington DC and around the nation. Check out the latest in the December 17, 2012 edition.
Want State Net delivered to your inbox every week? Register for your complimentary subscription at: http://www.statenet.com.
New Force in Arizona Lobbying: Willetta Partners
Veterans Haener & Tassinari Joined by New Partner Tom FarleyContinue reading
UA Cancer Center – Phoenix Project Approved for Construction
The Arizona Board of Regents has given final project approval for construction of The University of Arizona Cancer Center – Phoenix outpatient clinic at the Phoenix Biomedical Campus.Continue reading
Partners work together to accelerate development of new treatments for multiple sclerosis
The National Multiple Sclerosis Society and Critical Path Institute Create the Multiple Sclerosis Outcome Assessments ConsortiumContinue reading
RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
RiboMed Biotechnologies Inc., a leading Epigenetics-Based Diagnostics company, today announced that the U.S. Patent and Trademark Office has issued three additional patents covering the use of their core technology, Abscription® (Abortive Transcription), for disease and biowarfare agent related biomarker detection. The patents expand protection to MethylMagnet® and MethylMeter®, RiboMed’s bisulfite-free DNA methylation detection products and assays, including a new prognostic test for brain cancer, G-CIMP DecisionDx. Continue reading